Table 2. Association between the protein levels of PAR4 and TFF2 with clinic-pathological data of colorectal cancer.
PAR4(TFF2) protein level | |||||||
---|---|---|---|---|---|---|---|
Total | Increased | Not increased | |||||
n = 66 | n = 57(46) | n = 9(20) | p | ||||
No. | No. | % | No. | % | |||
Gender | |||||||
Male | 35 | 31(26) | 89(74) | 4(9) | 11(26) | 0.724(0.389) | |
Female | 31 | 26(20) | 84(65) | 5(11) | 16(35) | ||
Age (year) | |||||||
<60 | 27 | 24(18) | 89(67) | 3(9) | 11(33) | 0.727(0.656) | |
≥60 | 39 | 33(28) | 85(72) | 6(11) | 15(28) | ||
Hematogeneous metastasis | |||||||
Negative | 57 | 48(40) | 84(70) | 9(17) | 16(30) | 0.341(1.000) | |
Positive | 9 | 9(6) | 100(67) | 0(3) | 0(33) | ||
TNM stage | |||||||
T1 + T2 | 12 | 9(9) | 75(75) | 3(3) | 25(25) | 0.347(0.743) | |
T3 + T4 | 54 | 48(37) | 89(69) | 6(17) | 11(31) | ||
Lymph node metastasis | |||||||
Negative | 29 | 26(18) | 90(62) | 3(11) | 10(38) | 0.0.720(0.233) | |
Positive | 37 | 31(28) | 84(76) | 6(9) | 16(24) | ||
Differentiation | |||||||
Poor | 14 | 9(6) | 64(43) | 5(8) | 36(57) | 0.017(0.022) | |
Well and moderated | 52 | 48(40) | 90(77) | 4(12) | 10(23) | ||
Tumor size | |||||||
≤3cm | 9 | 8(6) | 89(67) | 1(3) | 11(33) | 0.341(1.000) | |
>3cm | 57 | 49(40) | 86(70) | 8(17) | 14(30) |